当前位置: 首页 > 期刊 > 《中国医学创新》 > 2021年第5期
编号:186396
乳腺癌化疗性肝损伤相关危险因素的研究
http://www.100md.com 2021年5月8日 中国医学创新 2021年第5期
     刘欣金 龚立勤

    【摘要】 目的:探讨乳腺癌化疗性肝损伤的相关危险因素。方法:选择2015年1月-2019年12月在本院接受化疗的106例乳腺癌患者的资料进行回顾性分析。对全部患者发生化疗性肝损伤的情况进行描述。按照患者是否发生化疗性肝损伤分组,分为病例组33例和对照组73例。通过单因素分析与多因素分析的方式,筛选乳腺癌化疗性肝损伤的相关危险因素。结果:2015年1月-2019年12月在本院接受化疗的乳腺癌患者共106例,33例患者发生化疗性肝损伤,发病率为31.13%。年龄、BMI、化疗方案、乙肝病毒感染、糖尿病是乳腺癌患者发生化疗性肝损伤的独立危险因素(P<0.05)。结论:多种因素均可导致乳腺癌患者出现化疗性肝损伤,需要进行具有针对性的干预。

    【关键词】 乳腺癌 化疗性肝损伤 恶性肿瘤 毒副反应

    Study on Risk Factors Associated with Chemotherapy-induced Liver Injury in Breast Cancer/LIU Xinjin, GONG Liqin. //Medical Innovation of China, 2021, 18(05): -136

    [Abstract] Objective: To investigate the risk factors associated with chemotherapy-induced liver injury in breast cancer. Method: The data of 106 breast cancer patients who received chemotherapy in our hospital from January 2015 to December 2019 were retrospectively analyzed. The occurrence of chemotherapy-induced liver injury in all patients were described. Patients were divided into case group (n=33) and control group (n=73) according to the occurrence of chemotherapy-induced liver injury. Univariate analysis and multivariate analysis were used to screen the risk factors of breast cancer chemotherapy-induced liver injury. Result: In January 2015 to December 2019 ......

您现在查看是摘要页,全文长 11654 字符